Teriflunomide Tablet, Film Coated
Product Images NDC 62332-314

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Teriflunomide (NDC 62332-314). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Teriflunomide Structure)

Chemical structure of Teriflunomide. The molecular diagram depicts the arrangement of carbon, hydrogen, nitrogen, oxygen, and fluorine atoms characteristic of Teriflunomide's active ingredient.*

FDA Label Image

Teriflunomide-figure1.jpg (Teriflunomide Figure1)

A line graph depicting disability progression sustained over 12 weeks among three groups: Placebo, 7 mg Teriflunomide Tablets, and 14 mg Teriflunomide Tablets. The x-axis represents weeks, and the y-axis represents the percentage of disability progression. The graph includes a table showing the number of patients at risk for each group at various time points up to 108 weeks. Statistical significance is noted for the 14 mg dose compared to placebo.*

FDA Label Image

Fig2 (Teriflunomide Fig2)

A line graph showing the percentage of disability progression sustained for 12 weeks over a period of 108 weeks comparing placebo, 7 mg Teriflunomide tablets, and 14 mg Teriflunomide tablets. The graph includes a number-at-risk table below, indicating subject counts at various time points for each group. The 14 mg Teriflunomide group shows a statistically significant difference from placebo (p < 0.05).*

FDA Label Image

7 mg Wallet Card (Teriflunomide 7mg Wallet Card 1)

Packaging label for Teriflunomide Tablets 7 mg, oral film-coated tablets, labeled for prescription use. The label shows the product name, strength (7 mg per tablet), package count (28 tablets), and includes the labeler name Alembic Pharmaceuticals Inc. The design includes dosing instructions graphics and medication guide dispensing notes.*

FDA Label Image

7 mg Carton (Teriflunomide Carton 7mg 1)

Packaging label for Teriflunomide Tablets, 7 mg strength, film-coated oral tablets. The label indicates 28 tablets per package, with the labeler listed as Alembic Pharmaceuticals Inc. The label includes dosage and storage instructions, a barcode, and the manufacturer details for Alembic Pharmaceuticals Limited and Alembic Pharmaceuticals, Inc.*

FDA Label Image

14 mg Wallet Card (Teriflunomide 14mg Wallet Card 1)

Packaging label for Teriflunomide Tablets 14 mg, film-coated oral tablets. The label shows the tablet blister packs, dosage strength, quantity of 28 tablets, prescription status, and manufacturer Alembic Pharmaceuticals Inc. Includes NDC 62332-314-14 and medication guide reference.*

FDA Label Image

14 mg Carton (Teriflunomide Carton 14mg 1)

Packaging label for Teriflunomide Tablets 14 mg film-coated oral tablets by Alembic Pharmaceuticals Inc. The box contains 28 tablets and includes dosage strength prominently on the front and sides. Instructions for pharmacists and storage conditions are visible, along with manufacturer details and a barcode.*

FDA Label Image

Teriflunomide-7mg-30bl.jpg (Teriflunomide 7mg 30bl)

Label for Teriflunomide Tablets 7 mg, film-coated oral tablets by Alembic Pharmaceuticals Inc. The label states each tablet contains 7 mg teriflunomide, and the package contains 30 tablets. Instructions note usual dosage is one tablet once daily. The label includes NDC 62332-313-30, manufacturer details for Alembic Pharmaceuticals Limited in India and Alembic Pharmaceuticals, Inc. in the USA, and a dispenser instruction to provide the Medication Guide to patients.*

FDA Label Image

Teriflunomide-14mg-30bl.jpg (Teriflunomide 14mg 30bl)

Label for Teriflunomide Tablets, 14 mg per tablet, oral film-coated tablets. The label shows the NDC 62332-314-30 and states a package quantity of 30 tablets. It includes the manufacturer Alembic Pharmaceuticals Limited, Gujarat, India, and Alembic Pharmaceuticals, Inc., Bedminster, NJ. The label also provides storage instructions and a pharmacist dispensing advisory.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.